Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[White coat hypertension].

P Lantelme1, H Milon

  • 1Service de cardiologie, hôpital de la Croix-Rousse, EA 645, 103, Grande-rue de la Croix-Rousse, 69004 Lyon.

Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[The optimal work-up before TAVI].

Annales de cardiologie et d'angeiologie·2019
Same author

Position paper of French Interventional Group (GACI) for TAVI in France in 2018.

Annales de cardiologie et d'angeiologie·2018
Same author

[Comparison of four formulas of adjusting QT interval for the heart rate in young elite athletes].

Annales de cardiologie et d'angeiologie·2016
Same author

[Renal denervation for treating hypertension: experience at the University Hospital in Lyon].

Annales de cardiologie et d'angeiologie·2014
Same author

Gas chromatography-mass spectrometric determinations of abscisic acid levels in the cap and the apex of maize roots.

Planta·2014
Same author

[Athlete's heart in the young: electrocardiographic and echocardiographic patterns in 107 French athletes].

Annales de cardiologie et d'angeiologie·2013
Same journal

Radiokymographic study of the kinetics of the middle arc and the hils in the normal subject.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

A medication for angina pectoris and pre-fibrillatory conditions; 1262 F; six years of clinical experience; action mechanism.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Circulatory changes following the injection of hypertonic saline solutions; application to the study of angina pectoris.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Alterations in coronary circulation during aortic insufficiency in young subjects.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Cardio-esophageal auscultation.

Archives des maladies du coeur et des vaisseaux·2010
Same journal

Hypertensive accidents following the injection of acetylcholine.

Archives des maladies du coeur et des vaisseaux·2010
See all related articles

White coat hypertension and the white coat effect are distinct conditions impacting blood pressure readings. Differentiating them is crucial for accurate diagnosis and avoiding unnecessary drug therapy.

Area of Science:

  • Cardiology
  • Hypertension Research

Context:

  • White coat hypertension and white coat effect are prevalent clinical phenomena.
  • Distinguishing between these conditions is essential due to overlapping terminology but distinct clinical meanings.

Purpose:

  • To clarify the definitions and diagnostic challenges of white coat hypertension and white coat effect.
  • To highlight the implications of misdiagnosis in hypertension management.

Summary:

  • The white coat effect is a transient blood pressure increase due to physician presence, measurable via blood pressure monitoring.
  • White coat hypertension signifies elevated clinic blood pressure with normal readings outside the office.
  • Current assessment methods for the white coat effect are often inadequate, and definitions for white coat hypertension lack standardization.

Related Experiment Videos

Impact:

  • Accurate differentiation prevents misdiagnosis of severe or resistant hypertension, avoiding inappropriate treatment.
  • Understanding these conditions aids in appropriate patient management and prognosis evaluation.
  • Mild cardiovascular consequences typically do not warrant pharmacologic intervention.